Read More

AcelRx Pharmaceuticals’s Earnings: A Preview

AcelRx Pharmaceuticals (NASDAQ:ACRX) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate that AcelRx Pharmaceuticals will likely report an Earnings Per Share (EPS) of $-0.07

ACRX

Read More

AcelRx To Present On Effect Of Administration Of Sufentanil Sublingual Tablet On Reducing Post-Operative Recovery Time And Opioid Use In Plastic Surgery At The Annual Miami Cosmetic Surgery Event Aug. 27

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today

ACRX